Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immix Biopharma, Inc. (IMMX)
NASDAQ:IMMX
RESEARCH TOOLSreports
Holding IMMX?
Track your performance easily
IMMX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.26 - $7.75
Previous Close$1.72
Volume83.42K
Average Volume (3M)140.08K
Market Cap
$47.21M
Enterprise Value$24.33M
Total Cash (Recent Filing)$23.98M
Total Debt (Recent Filing)$1.09M
Price to Earnings (P/E)―
Beta0.53
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.86
Shares Outstanding27,450,479
10 Day Avg. Volume173,771
30 Day Avg. Volume140,080
Standard Deviation0.32
R-Squared0.00034
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)1.98
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.79
Forecast
1Y Price Target
$7.00Price Target Upside337.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Immix Biopharma, Inc. News
PremiumCompany Announcements
Immix Biopharma Shareholders Back Growth and Governance Changes
Ownership Overview
40.36% Insiders
2.76% Mutual Funds
0.04% Other Institutional Investors
54.26% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IMMX FAQ
What was Immix Biopharma, Inc.’s price range in the past 12 months?
Immix Biopharma, Inc. lowest stock price was $1.26 and its highest was $7.75 in the past 12 months.
What is Immix Biopharma, Inc.’s market cap?
Currently, no data Available
When is Immix Biopharma, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Immix Biopharma, Inc.’s earnings last quarter?
Currently, no data Available
Is Immix Biopharma, Inc. overvalued?
According to Wall Street analysts Immix Biopharma, Inc.’s price is currently Undervalued.
Does Immix Biopharma, Inc. pay dividends?
Immix Biopharma, Inc. does not currently pay dividends.
What is Immix Biopharma, Inc.’s EPS estimate?
Immix Biopharma, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Immix Biopharma, Inc. have?
Immix Biopharma, Inc. has 27,450,480 shares outstanding.
What happened to Immix Biopharma, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Immix Biopharma, Inc.?
Among the largest hedge funds holding Immix Biopharma, Inc.’s share is Invst, LLC. It holds Immix Biopharma, Inc.’s shares valued at 53K.
---
Immix Biopharma, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.00 (337.50% Upside)
$7.00 (337.50% Upside)
Blogger Sentiment
Bullish
IMMX Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $89.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 1.3%
Last 30 Days ▼ 3.3%
Last 30 Days ▼ 3.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.27%
12-Months-Change
Fundamentals
Return on Equity
-102.49%
Trailing 12-Months
Asset Growth
85.24%
Trailing 12-Months
Company Description
Immix Biopharma, Inc.
Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation.
---
IMMX Stock 12 Month Forecast
Average Price Target
$7.00
▲(337.50% Upside)
Technical Analysis
Eloxx Pharmaceuticals
―
Aptevo Therapeutics
―
Gritstone Oncology
―
TRACON Pharmaceuticals
―
Best Analysts Covering IMMX
1 Year
1 Year Success Rate
1/3 ratings generated profit
1 Year Average Return
-2.73%
reiterated a buy rating 19 days ago
Copying Robert Burns's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -2.73% per trade.
---